UBS AM
LH icon

UBS AM’s Labcorp LH Stock Holding History

UBS AM’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248M Sell
887,431
-12,771
-1% -$3.36M 0.05% 332
2026
Q1 		$240M Buy
900,202
+27,697
+3% +$7.5M 0.05% 315
2025
Q4 		$219M Sell
872,505
-10,216
-1% -$2.71M 0.05% 337
2025
Q3 		$253M Sell
882,721
-155,113
-15% -$41.6M 0.06% 303
2025
Q2 		$272M Buy
1,037,834
+24,308
+2% +$5.92M 0.06% 322
2025
Q1 		$236M Buy
1,013,526
+29,299
+3% +$7.11M 0.06% 327
2024
Q4 		$226M Buy
984,227
+70,208
+8% +$16.1M 0.05% 336
2024
Q3 		$204M Buy
914,019
+49,203
+6% +$10.8M 0.05% 345
2024
Q2 		$176M Sell
864,816
-472,203
-35% -$96.1M 0.05% 335
2024
Q1 		$292M Buy
1,337,019
+143,574
+12% +$31.6M 0.1% 191
2023
Q4 		$271M Buy
1,193,445
+2,966
+0.2% +$623K 0.11% 203
2023
Q3 		$239M Sell
1,190,479
-205,964
-15% -$43.4M 0.11% 195
2023
Q2 		$275M Hold
1,396,443
– – 0.13% 161
2023
Q1 		$275M Sell
1,396,443
-40,516
-3% -$8.34M 0.13% 161
2022
Q4 		$291M Buy
1,436,959
+19,586
+1% +$3.83M 0.15% 155
2022
Q3 		$249M Buy
1,417,373
+14,151
+1% +$2.9M 0.14% 156
2022
Q2 		$283M Buy
1,403,222
+144,475
+11% +$30.8M 0.15% 145
2022
Q1 		$285M Buy
1,258,747
+110,409
+10% +$26M 0.12% 170
2021
Q4 		$310M Buy
1,148,338
+362
+0% +$89.6K 0.12% 184
2021
Q3 		$278M Sell
1,147,976
-29,064
-2% -$7.32M 0.12% 184
2021
Q2 		$279M Sell
1,177,040
-243,394
-17% -$55.5M 0.12% 182
2021
Q1 		$311M Buy
1,420,434
+159,714
+13% +$32.1M 0.14% 153
2020
Q4 		$220M Buy
1,260,720
+60,199
+5% +$10.4M 0.1% 201
2020
Q3 		$194M Sell
1,200,521
-213,193
-15% -$33.8M 0.1% 181
2020
Q2 		$202M Sell
1,413,714
-223,573
-14% -$30.9M 0.12% 162
2020
Q1 		$178M Sell
1,637,287
-141,355
-8% -$20.4M 0.13% 160
2019
Q4 		$258M Sell
1,778,642
-101,900
-5% -$14.7M 0.16% 124
2019
Q3 		$271M Sell
1,880,542
-8,426
-0.4% -$1.23M 0.18% 108
2019
Q2 		$281M Sell
1,888,968
-52,432
-3% -$7.32M 0.2% 100
2019
Q1 		$255M Sell
1,941,400
-93,933
-5% -$11.6M 0.19% 108
2018
Q4 		$221M Buy
2,035,333
+119,832
+6% +$16.1M 0.19% 110
2018
Q3 		$286M Sell
1,915,501
-3,238
-0.2% -$493K 0.21% 94
2018
Q2 		$296M Sell
1,918,739
-9,802
-0.5% -$1.48M 0.23% 87
2018
Q1 		$268M Sell
1,928,541
-152,062
-7% -$22.3M 0.21% 103
2017
Q4 		$285M Buy
2,080,603
+128,767
+7% +$17M 0.24% 88
2017
Q3 		$253M Buy
1,951,836
+155,637
+9% +$20.8M 0.23% 92
2017
Q2 		$238M Buy
1,796,199
+742,455
+70% +$90.9M 0.23% 94
2017
Q1 		$130M Buy
1,053,744
+17,620
+2% +$2.09M 0.13% 170
2016
Q4 		$114M Buy
1,036,124
+30,002
+3% +$3.33M 0.13% 179
2016
Q3 		$119M Buy
1,006,122
+315,365
+46% +$37.2M 0.13% 176
2016
Q2 		$77.3M Buy
690,757
+313,339
+83% +$33.7M 0.09% 251
2016
Q1 		$38M Buy
377,418
+41,644
+12% +$3.99M 0.04% 437
2015
Q4 		$35.7M Sell
335,774
-174,244
-34% -$18M 0.04% 462
2015
Q3 		$47.5M Sell
510,018
-604,049
-54% -$62.5M 0.05% 385
2015
Q2 		$116M Sell
1,114,067
-52,447
-4% -$5.46M 0.11% 206
2015
Q1 		$126M Sell
1,166,514
-25,438
-2% -$2.62M 0.12% 194
2014
Q4 		$110M Buy
1,191,952
+7,066
+0.6% +$624K 0.11% 223
2014
Q3 		$104M Sell
1,184,886
-74,510
-6% -$6.73M 0.1% 220
2014
Q2 		$111M Buy
1,259,396
+822,986
+189% +$71.3M 0.11% 213
2014
Q1 		$36.8M Buy
436,410
+47,714
+12% +$3.8M 0.04% 480
2013
Q4 		$30.5M Sell
388,696
-37,263
-9% -$3.18M 0.03% 506
2013
Q3 		$36.3M Sell
425,959
-1,620
-0.4% -$136K 0.04% 415
2013
Q2 		$36.8M Buy
+427,579
New +$35.5M 0.05% 399

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM's LH Position: Q2 2026 in Review

UBS AM reduced its Labcorp (LH) stake by 1.4% in Q2 2026, selling an estimated $3.36M and leaving 887,431 shares worth $248M. The position accounts for 0.05% of the portfolio, ranked #332.

UBS AM first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $311M in Q1 2021. 1,055 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • UBS AM held 887,431 shares of Labcorp worth $248M as of Q2 2026.
  • UBS AM sold 12,771 Labcorp shares in Q2 2026, an estimated $3.36M.
  • Labcorp made up 0.05% of UBS AM's portfolio in Q2 2026, its #332 holding.
  • UBS AM first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Labcorp position peaked at $311M in Q1 2021.
  • 1,055 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.